0000891293-15-000035.txt : 20150923
0000891293-15-000035.hdr.sgml : 20150923
20150923182015
ACCESSION NUMBER: 0000891293-15-000035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150921
FILED AS OF DATE: 20150923
DATE AS OF CHANGE: 20150923
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CTI BIOPHARMA CORP
CENTRAL INDEX KEY: 0000891293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911533912
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 2062827100
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER COMPANY:
FORMER CONFORMED NAME: CELL THERAPEUTICS INC
DATE OF NAME CHANGE: 19960321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIANCO JAMES A
CENTRAL INDEX KEY: 0001198554
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12465
FILM NUMBER: 151121729
FORMER NAME:
FORMER CONFORMED NAME: BLANCO JAMES A
DATE OF NAME CHANGE: 20021015
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-09-21
0
0000891293
CTI BIOPHARMA CORP
ctic
0001198554
BIANCO JAMES A
3101 WESTERN AVE
SUITE 600
SEATTLE
WA
98121
1
1
0
0
President and CEO
Common Stock
2015-09-21
4
A
0
507603
0
A
3821519
D
As disclosed by CTIC in a Form 8-K filed on 1/31/14, CTIC granted a bonus opportunity to the reporting person that is payable in shares of CTIC common stock upon the achievement of certain performance goals. This transaction reflects the issuance of common stock by CTIC pursuant to the award in connection with CTIC's determination that the Pacritinib Phase III goal under the award has been satisfied.
By: Louis A. Bianco, Attorney-in-fact For: James A. Bianco
2015-09-23